A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread

NCT07256223 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Clear Cell Renal Cell Cancer (ccRCC)
Liver Metastasis

Interventions

DRUG: Envafolimab+Lenvatinib

Sponsor

Fudan University

Collaborators

[object Object]